NCT02516085View on ClinicalTrials.gov

Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

Metformin

DRUG

L-Arginine

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02516085 - Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin | Biotech Hunter | Biotech Hunter